Lista de obras - Hans Adomat - Dominio Público Uruguay

A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer

artículo científico publicado en 2009

A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer ⬇️

artículo científico publicado el 1 de junio de 2012

Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro

artículo científico publicado en 2013

Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease

artículo científico publicado en 2013

Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer

artículo científico publicado en 2014

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance

artículo científico publicado en 2010

Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts

artículo científico publicado en 2007

Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells

artículo científico publicado en 2015

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model

artículo científico publicado en 2015

Capsaicin: a novel radio-sensitizing agent for prostate cancer

artículo científico publicado en 2014

Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer ⬇️

artículo científico publicado el 12 de agosto de 2013

Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor

artículo científico publicado en 2014

Effect of noncompetitive proteasome inhibition on bortezomib resistance

artículo científico publicado en 2010

Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors

artículo científico publicado en 2005

Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes ⬇️

artículo científico publicado el 21 de junio de 2012

Genistein Increases Epidermal Growth Factor Receptor Signaling and Promotes Tumor Progression in Advanced Human Prostate Cancer ⬇️

artículo científico publicado el 16 de mayo de 2011

Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.

artículo científico publicado en 2004

Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor

artículo científico publicado en 2015

Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer

artículo científico publicado en 2014

Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol

artículo científico publicado en 2013

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors

artículo científico publicado en 2010

Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro

artículo científico publicado en 2014

Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo

artículo científico publicado en 2014

Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy

artículo científico publicado en 2009

Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis

artículo científico publicado en 2004

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

artículo científico publicado en 2015

Lista de obras de Hans Adomat

A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer

A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer ⬇️

Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro

Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease

Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance

Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts

Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model

Capsaicin: a novel radio-sensitizing agent for prostate cancer

Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer ⬇️

Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor

Effect of noncompetitive proteasome inhibition on bortezomib resistance

Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors

Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes ⬇️

Genistein Increases Epidermal Growth Factor Receptor Signaling and Promotes Tumor Progression in Advanced Human Prostate Cancer ⬇️

Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.

Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor

Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer

Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors

Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro

Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo

Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy

Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer